|

The latest continuous
glucose monitor: the MiniMed Paradigm REAL-Time
System
Photo: Medtronic
Diabetes
|
The saying "knowledge is power"
is seldom truer than in the case of diabetics, who need
constant blood sugar readings in order to receive the
best treatment. Now, new devices called continuous
glucose monitors aim to make diabetes easier
to track. These monitors take a reading every five minutes,
providing much more information about trends and patterns
than can be gleaned from traditional, intermittent finger
sticks. "These devices will really make a difference
in patient control," says Dr Bernard Zinman, director
of the diabetes clinic at Mount Sinai Hospital in Toronto.
The latest in a long line of attempts
at developing the ideal continuous monitor combines
a pager-like device with an insulin pump that can be
programmed by the patient to deliver insulin at varying
rates. Licensed in Canada several weeks before it was
granted FDA approval on April 13, the device is already
being used diagnostically by endocrinologists to help
patients better understand how to manage their disease.
"We use them in the same way a cardiologist would use
a Holter monitor to look at cardiac rhythms," says Dr
Hertzel Gerstein, an endocrinologist at Hamilton Health
Sciences.
KNOWLEDGE
IS BLISS
A sensor is inserted in the subcutaneous tissue of the
abdomen that relays regular readings taken from interstitial
fluid to a monitor that's worn on the belt. The device
isn't fully automated yet patients still have
to read and interpret the result. But it does bring
us one step closer to the coveted "closed loop system"
where diabetics won't have to think about if, when and
how much insulin they need. "We're putting people on
it for three days, and analyzing the data," explains
Dr Zinman. He says it's used primarily to help patients
understand what happens when they eat Chinese food,
or go for a run, for example.
By far the greatest advantage of
these devices is the pure wealth of information they
provide patients can observe the direction, duration,
frequency and possible causes of fluctuations in blood
glucose levels. But it's going to take some time and
lots of tests before patients will give up complete
control. "The consequences of even a tiny error [in
insulin administration] are huge," says Dr Gerstein.
"Right now, no one would trust their insulin management
to a machine, but that's what we're hoping for eventually."
STICKER
SHOCK
At this stage, the devices still have to be calibrated
several times a day with finger stick readings, so patients
aren't free of painful pricking just yet. And though
the accuracy of the devices particularly in the
hypoglycemic range has been called into question,
both Dr Zinman and Dr Gerstein agree that the real drawback
is cost, not accuracy. Each sensor lasts three days
and costs about $40 apiece, while the device itself
can run up to a couple thousand dollars. "It's not practical
for someone to wear all the time," says Dr Zinman. He
adds that while the cost-benefit ratio is a concern,
better glucose control would mean fewer complications
and tremendous savings for our healthcare system. "It's
remarkable that people with diabetes do as well as they
do now with intermittent monitoring."
|